Abstract
Aluminum injection in rabbits leads to neurofibrillary changes which are at light microscopic level similar to those found in Alzheimer's disease. We used this animal model to see whether changes in proteolytic activity occur that may affect protein degradation in the altered neurofibrillary structure. Rabbits were injected via the cisterna magna with aluminum chloride, and after ten days tissue was excised from the spinal cord, hippocampus, occipital lobe, and cerebellum. Sections from the hippocampus and spinal cord were examined for neurofibrillary changes; enzyme activity was measured in all four areas. The enzymes studied were cathepsins A, B, and D, and the angiotensin-converting enzyme. No significant differences could be established in enzymatic activity in aluminum-injected animals compared to controls. However, a significant decrease in Triton-soluble proteins was observed in the treated animals, which correlated with changes in neurofibrillary structure. This decrease was most noticeable in the spinal cord (from 16.6 to 12.5 mg/g).
Similar content being viewed by others
References
Zimmerman, U.-J.P., andSchlaepfer, W. W. 1982. Characterization of a brain calciumactivated protease that degrades neurofilament protein. Biochemistry 21:3977–3983.
Schlaepfer, W. W. 1983. Neurofilaments and the abnormal filaments of Alzheimer's disease. Pages 107–115, in Katzman, R. (ed.), Banbury Report 15, Biological Aspects of Alzheimer's Disease, Cold Spring Harbor Laboratory, New York.
Selkoe, D. J., Abraham, C., andIhara, Y. 1982. Brain transglutaminase: In vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. USA 79:6070–6074.
Iqbal, K., Zaidi, T., Thompson, C. H., Merz, P. A., andWisniewski, H. M. 1984. Alzheimer paired helical filaments: Bulk isolation, solubility, and protein composition. Acta Neuropathol. (Berl) 62:167–177.
Grundke-Iqbal, I., Iqbal, K., Tung, Y.-C., andWisniewski, H. M. 1984. Alzheimer paired helical filaments: Immunochemical identification of polypeptides. Acta Neuropathol. (Berl) 62:259–267.
Sajdel-Sulkowska, E. M., andMarotta, C. A. 1984. Alzheimer's disease brain. Alterations in RNA levels and in a ribonuclease-inhibitor complex. Science 225:947–949.
Cammer, W., Bloom, B. R., Norton, W. T., andGordon, S. 1978. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages. A possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. USA 75:1554–1558.
Smith, M. E., Chow, S. H., andRolph, R. H. 1981. Partial purification and characterization of neutral proteases in lymph nodes of rats with experimental allergic encephalomyelitis. Neurochem. Res. 6:901–912.
Smith, M. E., andAmaducci, L. A. 1982. Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis. Neurochem. Res. 7:541–548.
Banik, N. L., Hogan, E. L., Powers, J. M., andWhetstine, L. J. 1982. Degradation of cytoskeletal protein in experimental spinal cord injury. Neurochem. Res. 7:1465–1475.
Crapper, D. R., Krishman, S. S., andDalton, A. J. 1973. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180:511–513.
Crapper, D. R., Krishman, S. S., andQuittkat, S. 1976. Aluminum, neurofibrillary degeneration, and Alzheimer's disease. Brain 99:67–80.
Perl, D. P. 1983. Aluminum and Alzheimer's disease: Intraneuronal X-ray spectrometry studies. Pages 425–431,in Katzman, R. (ed.), Banbury Report 15, Biological Aspects of Alzheimer's Disease, Cold Spring Harbor Laboratory, New York.
McDermott, J. R., Smith, A. I., Iqbal, K., andWisniewski, H. M. 1979. Aluminum and Alzheimer's disease. Lancet 2:710.
McDermott, J. R., Smith, A. I., Iqbal, K., andWisniewski, H. M., 1979. Brain aluminum in aging and Alzheimer's disease. Neurology 29:809–814.
Markesbery, W. R., Ehmann, W. D., Hossain, T. I. M., Alauddin, M., andGoodin, D. T. 1981. Instrumental neutron activation analysis of brain aluminum in Alzheimer's disease and aging. Ann. Neurol. 10:511–516.
Terry, R. D., andPena, C. 1965. Experimental production of neurofibrillary degeneration. Electron microscopy, phosphatase histochemistry and electron probe analysis. J. Neuropathol. Exp. Neurol. 24:200–210.
Yates, C. M., Gordon, A., andWilson, H. 1976. Neurofibrillary degeneration induced in the rabbit by aluminum chloride: aluminum neurofibrillary tangles. J. Neuropathol. Appl. Neurobiol. 2:131–144.
Wisniewski, H., Narkiewicz, O., andWisniewski, K. 1967. Topography and dynamics of neurofibrillary degeneration in aluminum encephalopathy. Acta Neuropathol. (Berl) 9:127–133.
Wisniewski, K., Jervis, G. A., Moretz, R. C., andWisniewski, H. M. 1979. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann. Neurol. 5:288–294.
Wisniewski, H. M., Sturman, J. A., andShek, J. W. 1980. Aluminum chloride induced neurofibrillary changes in the developing rabbit: A chronic animal model. Ann. Neurol. 8:479–490.
Benuck, M., Berg, M. J., andMarks, N. 1982. Separate metabolic pathways for Leuenkephalin and Met-enkephalin-Arg6-Phe7 degradation by rat striatal synaptosomal membranes. Neurochem. Int. 4:389–396.
Arregui, A., Perry, E. K., Rossor, M. andTomlinson, B. E. 1982. Angiotensin converting enzyme in Alzheimer's disease: Increased activity in caudate nucleus and cortical areas. J. Neurochem. 38:1490–1492.
Marks, N., Sachs, L., andStern, F. 1981. Conversion of Met-enkephalin-Arg6-Phe7 by a purified brain carboxypeptidase (cathepsin A). Peptides 2:159–164.
Suhar, A. andMarks, N. 1979. Purification and properties of brain cathepsin B. Eur. J. Biochem. 101:23–30.
Banay-Schwartz, M., Bracco, F., DeGuzman, T., andLajtha, A. 1983. Developmental changes in the breakdown of brain tubulin by cerebral cathepsin D. Neurochem. Res. 8:51–61.
Piquilloud, Y. A., Reinharz, A., andRoth, M. 1970. Studies on the angiotensin converting enzyme with different substrates. Biochim. Biophys. Acta 206:136–142.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., andRandall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Bowen, D. M., Smith, C. B., andDavison, A. N. 1973. Molecular changes in senile dementia. Brain 96:849–856.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benuck, M., Iqbal, K., Wisniewski, H.M. et al. Proteolytic activity in brains of rabbits treated with aluminum. Neurochem Res 10, 729–736 (1985). https://doi.org/10.1007/BF00964531
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964531